6869 — Sysmex Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Sysmex, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	363,780	410,502	461,510	508,643	500,006
Cost of Revenue
Gross Profit	190,585	216,083	242,497	271,978	255,682
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	296,490	336,884	383,180	421,581	448,175
Operating Profit	67,290	73,618	78,330	87,062	51,831
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	64,346	68,713	74,600	79,221	49,051
Provision for Income Taxes
Net Income After Taxes	44,072	45,725	49,774	53,576	35,375
Minority Interest
Net Income Before Extraordinary Items
Net Income	44,093	45,784	49,639	53,669	35,457
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	44,093	45,784	49,639	53,669	35,457
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	72	73.3	81.1	89.6	70.3
Dividends per Share
Special Dividends per Share